Renal cell carcinoma other diagnostic studies: Difference between revisions
No edit summary |
|||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Kidney diseases]] | |||
[[Category:Types of cancer]] | |||
[[Category:Oncology]] | |||
[[Category:Nephrology]] | |||
[[Category:Mature chapter]] | |||
Revision as of 20:46, 12 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma other diagnostic studies |
|
Risk calculators and risk factors for Renal cell carcinoma other diagnostic studies |
Overview
Other Diagnostic Studies
At diagnosis, 30% of renal cell carcinoma has spread to that kidney's renal vein, and 5-10% has continued on into the inferior vena cava[1].
Percutaneous biopsy can be performed by a radiologist using ultrasound or computed tomography to guide sampling of the tumor for the purpose of diagnosis. However this is not routinely performed because when the typical imaging features of renal cell carcinoma are present, the possibility of an incorrectly negative result together with the risk of a medical complication to the patient make it unfavorable from a risk-benefit perspective.This is not completely accurate, there are new experimental treatments.
References
- ↑ Oto A, Herts BR, Remer EM, Novick AC. Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment. AJR Am J Roentgenol. 1998 Dec;171(6):1619-24. PMID 9843299.